Bixiye
ATTR Amyloidosis - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 2471 - 2480 ee natiijooyinka 4128
Bixiye
ATTR Amyloidosis - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP37-21 New Clinical Survey for Psychological and Neuropsychological Testing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP39-21 Claims Status Listing Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP34-21 Is Authorization Required (IAR) Tool for Outpatient Authorization on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP36-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: ZokinvyTM (lonafarnib) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP35-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Verquvo® (vericiguat) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP38-21 Commercial and MHCP Pharmacy Benefit Exclusion for Abecma®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP33-21 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) Criteria: Winlevi®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021